Bounedjar A, Benkali R, Badoui L, Abada M, Moumeni A, Marouani A, Sedkaoui C, Ammour H, Dib A, Braikia S, Reggad R, Zidane H, Taieb L, Mahfouf H, Belacel A, Mechiat Z, Maachou Y, Souilah S, Gamaz M, Reguig F, Tabouri S, Bouannika M, Ghomari S, Rostane A, Ougdi W, Belbachir L, Bousahba A, Seghier F, Megaiz A, Mesli Mohamed A, Gharnaout M, Ihadadenne D, Bensalem A, Namous Anissa S, Djeghim S, Khelifi Touhami S, Bouzid K, Kerboua E, Oukkal M, Hadjam F, Smaili F, Bekkouche S, Zidouni N, Mekideche D, Mebrek A, Douagui H, Abdelaziz R, Lemdani M, Malki G, Fissah A, Larbaoui B, Sadji N, Zeroual S, Filali T, Ayadi L, Youcef Ali L, Djebbar A, Heddane R, Haddad B, Djedi H, Yousfi A, Debbah L, Boualga K, Ouali L, Guettaf Fatima Z, Moussei A, Houri M, Haddouche A, and Kedar M
Background: Lung cancer is a major cause of death worldwide. However, few data on incidence, histologic types and mortality rates of lung cancer were available for Algeria., Methods: LuCaReAl is an ongoing descriptive, non-interventional, national, multicenter, prospective and longitudinal study conducted in Algeria, among oncologists and pulmonologists in public community and university hospitals. Median and interquartile ranges are displayed., Results: Between July 2016 and July 2017, 897 patients were included. Overall incidence of lung cancer was 3.4 [3.2;3.6] cases per 100,000 inhabitants; overall incidence by sex was 5.8 [5.4;6.2] for males and 1.0 [0.8;1.1] for females. Adenocarcinoma was the most common histologic type of cancer. Most tumors were diagnosed at Stage IV., Conclusion: The first results from the LuCaReAl study in Algeria showed that most patients are diagnosed with lung cancer at an advanced stage. The ongoing follow-up will next provide data on the survival and mortality rates., (Copyright © 2020. Published by Elsevier Ltd.)